Showing results (1381-1390 of 1,599) with videos related to
Sort By:
Pageof 160
Biorxiv : the Preprint Server for Biology|January 9, 2026
IKAROS Gene Regulatory Network Reveal ERG as a Vulnerability in B-cell Acute Lymphoblastic LeukemiaHana Paculova, Alyssa Richman, Joseph Boyd, et al.Journal of Cell Science|May 29, 2000
Groucho/TLE/R-esp proteins associate with the nuclear matrix and repress RUNX (CBF(alpha)/AML/PEBP2(alpha)) dependent activation of tissue-specific gene transcriptionA Javed, B Guo, S Hiebert, et al.Cancer|August 22, 2019
Transplantation in adults with relapsed/refractory acute lymphoblastic leukemia who are treated with blinatumomab from a phase 3 studyElias J Jabbour, Nicola Gökbuget, Hagop M Kantarjian, et al.The Journal of Biological Chemistry|May 20, 2008
The WWOX tumor suppressor is essential for postnatal survival and normal bone metabolismRami I Aqeilan, Mohammad Q Hassan, Alain de Bruin, et al.Journal of Cellular Biochemistry|January 10, 2003
Intranuclear trafficking of transcription factors: Requirements for vitamin D-mediated biological control of gene expressionGary S Stein, Jane B Lian, Janet L Stein, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 14, 2009
Reduced-intensity conditioning followed by peripheral blood stem cell transplantation for adult patients with high-risk acute lymphoblastic leukemiaAnthony S Stein, Joycelynne M Palmer, Margaret R O'Donnell, et al.Molecular Biology Reports|October 22, 2008
Elevated expression of Runx2 as a key parameter in the etiology of osteosarcomaSaminathan S Nathan, Barry P Pereira, Ye-Fang Zhou, et al.The Journal of Biological Chemistry|July 27, 2005
Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expressionTripti Gaur, Christopher J Lengner, Hayk Hovhannisyan, et al.Human Molecular Genetics|November 26, 2008
A Runx2 threshold for the cleidocranial dysplasia phenotypeYang Lou, Amjad Javed, Sadiq Hussain, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 28, 2016
KAE609 (Cipargamin), a New Spiroindolone Agent for the Treatment of Malaria: Evaluation of the Absorption, Distribution, Metabolism, and Excretion of a Single Oral 300-mg Dose of [14C]KAE609 in Healthy Male SubjectsSu-Er W Huskey, Chun-qi Zhu, Andreas Fredenhagen, et al.Pageof 160